@article{366be2ccde5c4ea8944f19ebadc9db79,
title = "Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes",
abstract = "A randomized clinical trial compared efficacy and toxicity of standard all-trans-retinoic acid (ATRA) plus chemotherapy versus ATRA plus arsenic trioxide in patients with newly diagnosed, low- or intermediate-risk acute promyelocytic leukemia (APL). Here, we report health-related quality-of-life (HRQOL) results.",
keywords = "allogeneic, allogeneic",
author = "Simona Sica and Fabio Efficace and Franco Mandelli and Giuseppe Avvisati and Francesco Cottone and Felicetto Ferrara and {Di Bona}, Eros and Giorgina Specchia and Massimo Breccia and Alessandro Levis and Olimpia Finizio and Kropp, {Maria Grazia} and Giuseppe Fioritoni and Elisa Cerqui and Marco Vignetti and Sergio Amadori and Schlenk, {Richard F.} and Uwe Platzbecker and Francesco Lo-Coco",
year = "2014",
doi = "10.1200/JCO.2014.55.3453",
language = "English",
volume = "32",
pages = "3406--3412",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "-American Society of Clinical Oncology. , 330 JOHN CARLYLE ST, STE 300, ALEXANDRIA, USA, VA, 22314preceden",
}